articleTop 1% cited
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2022 · Vol. 33(12) · pp. 1217–1238
John B.A.G. Haanen✉(The Netherlands Cancer Institute)Michel ObéidLavinia Spain(Monash University)Franck Carbonnel(Assistance Publique – Hôpitaux de Paris)Yin-Shuang Wang(The University of Texas MD Anderson Cancer Center)Caroline Robert(Université Paris-Saclay)Alexander R. Lyon(Royal Brompton Hospital)Wolfgang Wick(Heidelberg University)Marie Kostine(Hôpital Pellegrin)Solange PetersKarin Jordan(Klinikum Ernst von Bergmann)James Larkin(Royal Marsden NHS Foundation Trust)
Cancer Immunotherapy and BiomarkersDrug-Induced Adverse ReactionsColorectal Cancer Treatments and StudiesMedicineGuidelineImmunotherapyIntensive care medicineClinical PracticeOncologyInternal medicineFamily medicineCancerPathology
MeSH terms
Follow-Up StudiesHumansImmunologic FactorsImmunotherapy
Citations
1,025
FWCI
95.22
field-weighted impact
References
120
Percentile
100%
vs. same field & year
Citations per year
References
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
American Journal of Respiratory and Critical Care Medicine · 2013 · 4,194 citations
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · 8,055 citations
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology · 2018 · 3,616 citations
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2021 · 12,277 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.